{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:58:38Z","timestamp":1784221118886,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["20170160"],"award-info":[{"award-number":["20170160"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jval.2019.06.008","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T16:40:18Z","timestamp":1566837618000},"page":"1295-1302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Toward a Smaller Design for EQ-5D-5L Valuation Studies"],"prefix":"10.1016","volume":"22","author":[{"given":"Zhihao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Oppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gouke","family":"Bonsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Busschbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jval.2019.06.008_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","article-title":"A\u00a0program of methodological research to arrive at the new international EQ-5D-5L valuation protocol","volume":"17","author":"Oppe","year":"2014","journal-title":"Value Health"},{"issue":"suppl 1","key":"10.1016\/j.jval.2019.06.008_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1007\/s10198-013-0503-2","article-title":"Introducing the composite time trade-off: a test of feasibility and face validity","volume":"14","author":"Janssen","year":"2013","journal-title":"Eur J Health Econ"},{"issue":"10","key":"10.1016\/j.jval.2019.06.008_bib3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","article-title":"EuroQol protocols for time trade-off valuation of health outcomes","volume":"34","author":"Oppe","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2019.06.008_bib4","author":"Oppe"},{"issue":"2","key":"10.1016\/j.jval.2019.06.008_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11136-015-1086-4","article-title":"An EQ-5D-5L value set based on Uruguayan population preferences","volume":"25","author":"Augustovski","year":"2016","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2019.06.008_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jval.2016.11.016","article-title":"Estimating an EQ-5D-5L value set for China","volume":"20","author":"Luo","year":"2017","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.jval.2019.06.008_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"M Versteegh","year":"2016","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"A\u00a0time trade-off-derived value set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.jval.2019.06.008_bib9","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.jval.2019.06.008_bib10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jval.2016.03.1834","article-title":"Comparison of value set based on DCE and\/or TTO data: scoring for EQ-5D-5L health states in Japan","volume":"19","author":"Shiroiwa","year":"2016","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2019.06.008_bib11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40273-017-0538-9","article-title":"The Indonesian EQ-5D-5L value set","volume":"35","author":"Purba","year":"2017","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"6","key":"10.1016\/j.jval.2019.06.008_bib13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","article-title":"German value set for the EQ-5D-5L","volume":"36","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2019.06.008_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jval.2017.10.023","article-title":"Handling data quality issues to estimate the Spanish EQ-5D-5L value set using a hybrid interval regression approach","volume":"21","author":"Ramos-Goni","year":"2018","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2019.06.008_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40271-017-0278-0","article-title":"Assessing the use of a feedback module to model EQ-5D-5L health states values in Hong Kong","volume":"11","author":"Wong","year":"2018","journal-title":"Patient"},{"issue":"12","key":"10.1016\/j.jval.2019.06.008_bib16","doi-asserted-by":"crossref","first-page":"e0209344","DOI":"10.1371\/journal.pone.0209344","article-title":"Valuation of the EQ-5D-5L in Taiwan","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jval.2019.06.008_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"10.1016\/j.jval.2019.06.008_bib18","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s40273-018-0690-x","article-title":"Utility values for health states in Ireland: a value set for the EQ-5D-5L","volume":"36","author":"Hobbins","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"5","key":"10.1016\/j.jval.2019.06.008_bib19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s40273-018-0758-7","article-title":"EQ-5D-5L valuation for the Malaysian population","volume":"37","author":"Shafie","year":"2019","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hec.3560","article-title":"New methods for modelling EQ-5D-5L value sets: an application to English data","volume":"27","author":"Feng","year":"2018","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jval.2018.06.015","article-title":"Effect of health state sampling methods on model predictions of EQ-5D-5L values: small designs can suffice","volume":"22","author":"Yang","year":"2019","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2019.06.008_bib22","series-title":"Optimization of the design of multi-attribute vignette studies: a simulation study based on the multinational EQ-5D-5L pilot studies","author":"Bonsel","year":"2016"},{"issue":"7","key":"10.1016\/j.jval.2019.06.008_bib23","doi-asserted-by":"crossref","first-page":"A386","DOI":"10.1016\/j.jval.2016.09.228","article-title":"Using orthogonal design in selecting health states for the construction of EQ-5D-3L value set","volume":"19","author":"Yang","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2019.06.008_bib24","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1524-4733.2009.00565.x","article-title":"Why do patients with inflammatory arthritis often score states \"worse than death\" on the EQ-5D? An investigation of the EQ-5D classification system","volume":"12","author":"Harrison","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2019.06.008_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-4-25","article-title":"Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients","volume":"4","author":"Rashidi","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"10.1016\/j.jval.2019.06.008_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1467-8489.2007.00436.x","article-title":"Design efficiency for non-market valuation with choice modelling: how to measure it, what to report and why","volume":"52","author":"Scarpa","year":"2008","journal-title":"Aust J Agricultural Resource Econ"},{"issue":"4","key":"10.1016\/j.jval.2019.06.008_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jval.2017.09.001","article-title":"Selecting health states for EQ-5D-3L valuation studies: statistical considerations matter","volume":"21","author":"Yang","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jval.2018.05.010","article-title":"Overview, update and lessons learned from the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol","volume":"22","author":"Stolk","year":"2019","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.jval.2019.06.008_bib29","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jval.2016.10.012","article-title":"Quality control process for EQ-5D-5L valuation studies","volume":"20","author":"Ramos-Goni","year":"2017","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2019.06.008_bib30","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"issue":"7","key":"10.1016\/j.jval.2019.06.008_bib31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jval.2017.03.013","article-title":"Less is more: cross-validation testing of simplified nonlinear regression model specifications for EQ-5D-5L health state values","volume":"20","author":"Rand-Hendriksen","year":"2017","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.jval.2019.06.008_bib32","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.3747\/co.22.2592","article-title":"Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer","volume":"22","author":"Lien","year":"2015","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.jval.2019.06.008_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.vhri.2012.03.022","article-title":"Health care system information sharing: a step toward Better health globally","volume":"1","author":"Eldessouki","year":"2012","journal-title":"Value Health Reg Issues"},{"issue":"2","key":"10.1016\/j.jval.2019.06.008_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J\u00a0Health Econ"},{"issue":"2","key":"10.1016\/j.jval.2019.06.008_bib35","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0272989X10379646","article-title":"Estimating a preference-based index for a 5-dimensional health state classification for asthma derived from the asthma quality of life questionnaire","volume":"31","author":"Yang","year":"2011","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2019.06.008_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-3-13","article-title":"Estimating a preference-based index for a menopause specific health quality of life questionnaire","volume":"3","author":"Brazier","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"10.1016\/j.jval.2019.06.008_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jval.2011.01.004","article-title":"Deriving a preference-based measure for\u00a0cancer using the EORTC QLQ-C30","volume":"14","author":"Rowen","year":"2011","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.jval.2019.06.008_bib38","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/MLR.0000000000000283","article-title":"Valuation and modeling of EQ-5D-5L health states using a hybrid approach","volume":"55","author":"Ramos-Goni","year":"2017","journal-title":"Med Care"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519322594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301519322594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:57:54Z","timestamp":1778590674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301519322594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1098301519322594"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2019.06.008","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toward a Smaller Design for EQ-5D-5L Valuation Studies","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2019.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}